SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-018934
Filing Date
2018-04-03
Accepted
2018-04-03 16:03:31
Documents
7
Period of Report
2018-04-23
Effectiveness Date
2018-04-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv490229_def14a.htm DEF 14A 190903
2 GRAPHIC image_001.jpg GRAPHIC 3647
3 GRAPHIC image_002.jpg GRAPHIC 1794
4 GRAPHIC image_003.jpg GRAPHIC 2008
5 GRAPHIC image_004.jpg GRAPHIC 1793
6 GRAPHIC image_019.jpg GRAPHIC 89782
7 GRAPHIC image_020.jpg GRAPHIC 74996
  Complete submission text file 0001144204-18-018934.txt   432554
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 18733304
SIC: 2834 Pharmaceutical Preparations